[go: up one dir, main page]

AU3306997A - Use of h2-antagonists for the manufacture of a topical composition for the treatment of colds - Google Patents

Use of h2-antagonists for the manufacture of a topical composition for the treatment of colds

Info

Publication number
AU3306997A
AU3306997A AU33069/97A AU3306997A AU3306997A AU 3306997 A AU3306997 A AU 3306997A AU 33069/97 A AU33069/97 A AU 33069/97A AU 3306997 A AU3306997 A AU 3306997A AU 3306997 A AU3306997 A AU 3306997A
Authority
AU
Australia
Prior art keywords
colds
antagonists
manufacture
treatment
topical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33069/97A
Inventor
Robert Ernest Singer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of AU3306997A publication Critical patent/AU3306997A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cosmetics (AREA)
AU33069/97A 1996-06-12 1997-06-10 Use of h2-antagonists for the manufacture of a topical composition for the treatment of colds Abandoned AU3306997A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66238996A 1996-06-12 1996-06-12
US08662389 1996-06-12
PCT/US1997/009977 WO1997047292A1 (en) 1996-06-12 1997-06-10 Use of h2-antagonists for the manufacture of a topical composition for the treatment of colds

Publications (1)

Publication Number Publication Date
AU3306997A true AU3306997A (en) 1998-01-07

Family

ID=24657514

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33069/97A Abandoned AU3306997A (en) 1996-06-12 1997-06-10 Use of h2-antagonists for the manufacture of a topical composition for the treatment of colds

Country Status (8)

Country Link
EP (1) EP0954294A1 (en)
JP (1) JPH11513035A (en)
CN (1) CN1221338A (en)
AU (1) AU3306997A (en)
BR (1) BR9709792A (en)
CA (1) CA2257990A1 (en)
ID (1) ID19099A (en)
WO (1) WO1997047292A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6846478B1 (en) 1998-02-27 2005-01-25 The Procter & Gamble Company Promoting whole body health
WO2001074780A1 (en) * 2000-03-21 2001-10-11 Astion Development Aps Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist
MXPA03000041A (en) * 2000-06-30 2003-10-15 Procter & Gamble Promoting whole body health.
PE20020102A1 (en) 2000-06-30 2002-03-06 Procter & Gamble TOPICAL ORAL COMPOSITION INCLUDING A MODULATING AGENT OF THE HOST RESPONSE TO PERIODONTAL PATHOGENS
JP2003321366A (en) * 2002-04-30 2003-11-11 Ucb Japan Kk Prophylactic or treating agent for inflammatory enteropathy
ITMI20031640A1 (en) * 2003-08-08 2005-02-09 Mipharm S P A BASE FOR BIOADHESIVE GEL.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749700A (en) * 1984-10-23 1988-06-07 Nastech Pharmaceutical Co, Inc. Novel methods of administering antihistamines, antinausea and antiemetic pharmaceutical agents and novel dosage forms containing same
JPH06506198A (en) * 1991-03-04 1994-07-14 ワーナー−ランバート・コンパニー Novel salt/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis

Also Published As

Publication number Publication date
ID19099A (en) 1998-06-11
BR9709792A (en) 1999-08-10
JPH11513035A (en) 1999-11-09
CA2257990A1 (en) 1997-12-18
WO1997047292A1 (en) 1997-12-18
CN1221338A (en) 1999-06-30
EP0954294A1 (en) 1999-11-10

Similar Documents

Publication Publication Date Title
AU3201095A (en) Substituted thiazoles for the treatment of inflammation
AU7859800A (en) Topical nasal treatment
AU3548795A (en) Benzopyranopyrazolyl derivatives for the treatment of inflammation
AU3541095A (en) Surgical face mask
AU2805195A (en) Therapeutic compounds
AU6525296A (en) Wound treatment composition
AU2388895A (en) Substituted cyclopentadienyl compounds for the treatment of inflammation
AU758325C (en) Imidazole compounds and medicinal use thereof
AU5988896A (en) Topical composition for fungal treatment
AU2270695A (en) Active compounds
EP0765663A3 (en) Use of dienogest for the manufacture of a medicament for the treatment of the skin by topical application
AU2424895A (en) Substituted spirodienes for the treatment of inflammation
AU5651799A (en) Remedies for photochemotherapy
AU5056099A (en) Compounds for use in the treatment of inflammation
AU5929499A (en) A wound treatment composition and a wound dressing containing it
AU6698996A (en) A film for topical use in the treatment of wounds
AU3187595A (en) Compounds for the treatment of restenosis
AU3009195A (en) Wound healing formula
AU3750395A (en) Wound treatment composition
AU2310395A (en) Topical retinal-based composition
AU3306997A (en) Use of h2-antagonists for the manufacture of a topical composition for the treatment of colds
AU2068295A (en) Skin treatment composition
AU697193B2 (en) Antiseptic dermatological composition and process for its manufacture
AU6251098A (en) Composition for use as a fungistat and for the treatment of fungal infections
AU2154695A (en) Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof